INR 45.25
(-0.26%)
Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
---|---|---|---|---|---|---|
Operating Cash Flow | 76.02 Billion | 29.82 Billion | 43.98 Billion | 24.22 Billion | -106.58 Billion | 41.89 Billion |
Net Income | 16.53 Billion | 28.69 Billion | 17.15 Billion | -1.06 Billion | -37.12 Billion | -43.05 Billion |
Depreciation & Amortization | 2.8 Billion | 2.17 Billion | 1.64 Billion | 1.34 Billion | 1.37 Billion | 1.36 Billion |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | 20.73 Billion | -32.48 Billion | -19.27 Billion | -28.7 Billion | -146.87 Billion | 10.99 Billion |
Other non-cash items | 38.75 Billion | 31.44 Billion | 44.45 Billion | 52.64 Billion | 76.04 Billion | 72.58 Billion |
Investing Cash Flow | -256.12 Billion | -2.67 Billion | -1.99 Billion | -1.54 Billion | -1.12 Billion | -137.41 Million |
Investments in PPE | -3.53 Billion | -2.88 Billion | -2.16 Billion | -1.64 Billion | -1.43 Billion | -755.04 Million |
Acquisitions | 546.56 Million | 67.3 Million | 67.73 Million | - | 200.14 Million | 250.17 Million |
Investment purchases | - | - | -35.76 Billion | -29.21 Billion | -92.97 Billion | -118.6 Billion |
Sales/Maturities of investments | 19.06 Billion | 9.1 Billion | 35.85 Billion | - | - | - |
Other Investing Activities | 587.06 Million | -8.95 Billion | 100 Thousand | 29.31 Billion | 93.07 Billion | 118.97 Billion |
Financing Cash Flow | 182.87 Billion | -3.35 Billion | -16.36 Billion | 32.65 Billion | 42.82 Billion | 54.49 Billion |
Debt repayment | -44.95 Billion | -10 Billion | -18.59 Billion | -3.12 Billion | -15.75 Billion | -9.83 Billion |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | -26 Billion | - | - | - |
Common Stock Issuance | - | - | 26 Billion | 26 Billion | 42.72 Billion | 33.42 Billion |
Other Financing Activities | -1.87 Billion | 6.64 Billion | 30.46 Billion | 9.78 Billion | 15.85 Billion | 30.9 Billion |
Accounts receivables | - | - | - | - | - | - |
Accounts payables | - | - | - | - | - | - |
Inventory | - | - | - | - | - | - |
Other working capital | -47.1 Billion | - | - | - | - | - |
Cash at beginning of period | 287.28 Billion | 261.47 Billion | 236 Billion | 178.06 Billion | 244.32 Billion | 147.48 Billion |
Cash at end of period | 290.25 Billion | 287.28 Billion | 261.47 Billion | 236 Billion | 178.06 Billion | 244.32 Billion |
Capital Expenditure | -3.53 Billion | -2.88 Billion | -2.16 Billion | -1.64 Billion | -1.43 Billion | -755.04 Million |
Effect of forex changes on cash | 199.59 Million | 2 Billion | -145.6 Million | 2.6 Billion | -1.37 Billion | 581.56 Million |
Net cash flow / Change in cash | 2.97 Billion | 25.8 Billion | 25.47 Billion | 57.94 Billion | -66.25 Billion | 96.84 Billion |
Free Cash Flow | 72.48 Billion | 26.94 Billion | 41.82 Billion | 22.57 Billion | -108.01 Billion | 41.14 Billion |
Breakdown | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY | 2022 Q4 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | 16.53 Billion | 5.05 Billion | 4.03 Billion | 2.24 Billion | 28.69 Billion | 5.57 Billion |
Depreciation & Amortization | 2.8 Billion | - | - | - | 2.17 Billion | - |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | 20.73 Billion | - | - | - | -32.48 Billion | - |
Other non-cash items | 38.75 Billion | -5.05 Billion | -4.03 Billion | -2.24 Billion | 31.44 Billion | -5.57 Billion |
Investing Cash Flow | -256.12 Billion | - | - | - | -2.67 Billion | - |
Investments in PPE | -3.53 Billion | - | - | - | -2.88 Billion | - |
Acquisitions | 546.56 Million | - | - | - | 67.3 Million | - |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | 19.06 Billion | - | - | - | 9.1 Billion | - |
Other Investing Activities | - | - | - | - | -8.95 Billion | - |
Financing Cash Flow | 182.87 Billion | - | - | - | -3.35 Billion | - |
Debt repayment | -44.95 Billion | - | - | - | -10 Billion | - |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | - | - | - | - | 6.64 Billion | - |
Accounts receivables | - | - | - | - | - | - |
Accounts payables | - | - | - | - | - | - |
Inventory | - | - | - | - | - | - |
Other working capital | - | - | - | - | - | - |
Cash at beginning of period | 287.28 Billion | - | - | - | 261.47 Billion | - |
Cash at end of period | 290.25 Billion | 5.05 Billion | 4.03 Billion | 2.24 Billion | 287.28 Billion | 5.57 Billion |
Capital Expenditure | -3.53 Billion | - | - | - | -2.88 Billion | - |
Effect of forex changes on cash | 199.59 Million | - | - | - | 2 Billion | - |
Net cash flow / Change in cash | 2.97 Billion | 5.05 Billion | 4.03 Billion | 2.24 Billion | 25.8 Billion | 5.57 Billion |
Free Cash Flow | 72.48 Billion | 5.05 Billion | 4.03 Billion | 2.24 Billion | 26.94 Billion | 5.57 Billion |
4513
3325
AIDX
1541
UFCS
TRMED